kancera ab (KAN:Stockholm)

Last kr0.91 SEK

Change Today +0.12 / 15.19%

Volume 148.9K

KAN On Other Exchanges

Symbol

Exchange

KAN:SS

Stockholm

As of 12:00 PM 05/17/13 All times are local (Market data is delayed by at least 15 minutes).

kancera ab (KAN) Snapshot

Open kr0.80		Previous Close kr0.79
Day High kr0.92		Day Low kr0.80
52 Week High 05/22/12 - kr3.00		52 Week Low 11/16/12 - kr0.53
Market Cap 29.4M		Average Volume 10 Days 118.6K
EPS TTM kr-2.02		Shares Outstanding 32.3M
EX-Date --		P/E TM --
Dividend --		Dividend Yield --

Current Stock Chart for KANCERA AB (KAN)

KAN:SS Historical Stock Quote
KAN:SS Advanced Stock Chart

Related News

No related news articles were found.

kancera ab (KAN) Related Businessweek News

No Related Businessweek News Found

kancera ab (KAN) Details

Kancera AB, a biotechnology company, engages in the development and sale of drug candidates for the treatment of cancer. It is developing the treatment for both haematological forms of cancer (leukaemia) and solid tumors. The company also develops cancer models and stem cell-based techniques to study the effect of the candidates, long before start of clinical trials. Kancera AB was founded in 2010 and is based in Stockholm, Sweden.

Detailed KAN:SS Company Description...

www.kancera.com

Founded in 2010

kancera ab (KAN) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

kancera ab (KAN) Key Developments

Kancera AB Announces Group and Parent Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2012

Feb 22 13

Kancera AB announced group and parent earnings results for the fourth quarter and full year ended December 31, 2012. For the quarter, on group basis, the company reported net turnover of SEK 1,362,000 against SEK 3,224,000 a year ago. Operating loss was SEK 10,537,000 against SEK 5,159,000 a year ago. Net loss attributable to shareholders of the parent company was SEK 10,726,000 against SEK 5,020,000 a year ago. Cash outflow from operating activities was SEK 3,427,000 against SEK 3,280,000 a year ago. Loss per share, before and after dilution was SEK 0.60 against SEK 0.33 a year ago. Free cash outflow available to investor was SEK 3,427,000 compared to SEK 4,939,000 for the last year. For the quarter, on parent basis, the company reported operating loss of SEK 1,705,000 against SEK 7,883,000 a year ago. Net loss was SEK 4,025,000 against SEK 7,765,000 a year ago. Cash outflow from operating activities was SEK 7,187,000 against SEK 7,044,000 a year ago. Free cash outflow available to investor was SEK 7,187,000 compared to SEK 7,044,000 for the last year. For the full year, on group basis, the company reported net turnover of SEK 3,517,000 against SEK 7,069,000 a year ago. Operating loss was SEK 33,293,000 against SEK 18,372,000 a year ago. Net loss attributable to shareholders of the parent company was SEK 33,488,000 against SEK 18,410,000 a year ago. Cash outflow from operating activities was SEK 26,928,000 against SEK 16,100,000 a year ago. Loss per share, before and after dilution was SEK 02.02 against SEK 1.35a year ago. Free cash outflow available to investor was SEK 26,928,000 compared to SEK 16,100,000 for the last year. For the full year, on parent basis, the company reported operating loss of SEK 21,243,000 against SEK 23,748,000 a year ago. Net loss was SEK 23,500,000 against SEK 23,665,000 a year ago. Cash outflow from operating activities was SEK 22,536,000 against SEK 22,814,000 a year ago. Free cash outflow available to investor was SEK 22,536,000 compared to SEK 23,134,000 for the last year.

Kancera AB to Report Fiscal Year 2012 Final Results on May 03, 2013

Feb 20 13

Kancera AB announced that they will report fiscal year 2012 final results on May 03, 2013

Kancera AB to Report Fiscal Year 2012 Results on Feb 23, 2013

Feb 20 13

Kancera AB announced that they will report fiscal year 2012 results on Feb 23, 2013